Brickell Biotech Analysis
| BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell Biotech is overvalued with Real Value of 1.52 and Hype Value of 1.79. The main objective of Brickell Biotech delisted stock analysis is to determine its intrinsic value, which is an estimate of what Brickell Biotech is worth, separate from its market price. There are two main types of Brickell Biotech's stock analysis: fundamental analysis and technical analysis.
The Brickell Biotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brickell Biotech's ongoing operational relationships across important fundamental and technical indicators.
Brickell |
Brickell Stock Analysis Notes
About 13.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Brickell Biotech recorded a loss per share of 0.42. The entity last dividend was issued on the 3rd of September 2019. The firm had 1:45 split on the 5th of July 2022. Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people. For more info on Brickell Biotech please contact Attorney Brown at 720 505 4755 or go to https://www.brickellbio.com.Brickell Biotech Investment Alerts
| Brickell Biotech is not yet fully synchronised with the market data | |
| Brickell Biotech may become a speculative penny stock | |
| Brickell Biotech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M). | |
| Brickell Biotech has about 17.29 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Brickell Market Capitalization
The company currently falls under 'Nano-Cap' category with a total capitalization of 6.75 M.Brickell Biotech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brickell Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brickell Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Brickell Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Breton Jose over three months ago Acquisition by Breton Jose of 15000 shares of Brickell Biotech subject to Rule 16b-3 | ||
Veru Dennison T over three months ago Acquisition by Veru Dennison T of 19642 shares of Brickell Biotech subject to Rule 16b-3 | ||
Lyons Gary A over three months ago Disposition of 8631 shares by Lyons Gary A of Brickell Biotech at 0.94 subject to Rule 16b-3 | ||
Mcavoy David R. over three months ago Acquisition by Mcavoy David R. of 18124 shares of Brickell Biotech at 0.6697 subject to Rule 16b-3 | ||
Hardy Reginald L over six months ago Acquisition by Hardy Reginald L of 883 shares of Brickell Biotech subject to Rule 16b-3 |
Brickell Biotech Outstanding Bonds
Brickell Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brickell Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brickell bonds can be classified according to their maturity, which is the date when Brickell Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Brickell Biotech Predictive Daily Indicators
Brickell Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brickell Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Brickell Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Brickell Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brickell shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Brickell Biotech. By using and applying Brickell Stock analysis, traders can create a robust methodology for identifying Brickell entry and exit points for their positions.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Brickell Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |